EUVIMEDEUVIMED entdecken
Crossref

Coexisting inflammatory bowel disease in primary sclerosing cholangitis is associated with higher colorectal cancer and transplant risk

Chengu Niu iD, Jing Zhang, Prajjwol Bhatta, Kaiwen Zhu, Nagesh Jadhav, Patrick I Okolo, Asim Mushtaq, Ebubekir Daglilar

Journal of Internal Medicine · 2025

DOI: 10.1111/joim.70026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Internal Medicine, 2025. Verfasst von Chengu Niu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Residency Program, Rochester General Hospital, Rochester, New York, USA. Hauptthemen laut MEDLINE: Cholangitis, Sclerosing, Colorectal Neoplasms, Inflammatory Bowel Diseases, Liver Transplantation. Die Arbeit nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Primary sclerosing cholangitis (PSC) is often intertwined with inflammatory bowel disease (IBD), presenting a complex clinical scenario. The coexistence of IBD–PSC complicates disease management and progression, potentially exacerbating outcomes.

Objectives

This study aims to evaluate the specific impact of IBD in patients with PSC, focusing on both liver‐related and IBD‐specific clinical outcomes.

Methods

This retrospective study, utilizing the TriNetX database, performed propensity score matching to compare clinical outcomes between IBD–PSC and PSC‐only patients, as well as IBD–PSC and IBD‐only patients. Diagnoses were identified based on International Classification of Diseases‐10 coding.

Results

The study analyzed 1941 patients with IBD–PSC, 234,081 with IBD alone, and 628 with PSC alone. Patients with IBD–PSC had significantly higher mortality compared to IBD alone (16.0% vs. 7.5%; hazard ratio [HR]: 2.256, 95% confidence interval [CI]: 1.853–2.747, p < 0.001), as well as increased rates of hospitalization (32.8% vs. 14.5%; HR: 2.641, 95% CI: 2.213–3.152, p < 0.001) and intensive care unit admission (18.7% vs. 5.8%; HR: 3.691, 95% CI: 2.954–4.612, p < 0.001). Colorectal cancer was also more frequent in the IBD–PSC group (2.4% vs. 0.7%; HR: 3.370, 95% CI: 1.846–6.152, p < 0.001). When compared to PSC alone, IBD–PSC patients had a higher rate of liver transplantation (12.3% vs. 8.0%; HR: 1.492, 95% CI: 1.012–2.198, p = 0.042), whereas rates of hepatocellular carcinoma and cholangiocarcinoma were similar between groups.

Conclusions

Patients with coexisting IBD and PSC experience greater clinical severity, including higher mortality, hospitalization, and colorectal cancer risk. They also have increased liver transplant incidence. Further research is needed to explore underlying mechanisms and improve management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholangitis, SclerosingColorectal NeoplasmsInflammatory Bowel DiseasesLiver TransplantationHumansFemaleMaleRetrospective StudiesMiddle AgedAdultRisk FactorsPropensity ScoreAged

Stichwörter der Autor:innen

TriNetX databaseclinical outcomescoexistenceinflammatory bowel diseaseprimary sclerosing cholangitis

Autor:innen und Institutionen

  • Internal Medicine Residency Program, Rochester General Hospital, Rochester, New York, USA.
  • Rainier Springs Behavioral Health Hospital, Vancouver, Washington, USA.
  • Division of Gastroenterology, Rochester General Hospital, Rochester, New York, USA.
  • Division of Gastroenterology, Charleston Area Medical Center/CAMC Institute For Academic Medicine Program, Charleston, West Virginia, USA.

ORCID-Profile: Chengu Niu

Zitieren

APA

Niu, C., Zhang, J., Bhatta, P., Zhu, K., Jadhav, N., Okolo, P. I., Mushtaq, A., & Daglilar, E. (2025). Coexisting inflammatory bowel disease in primary sclerosing cholangitis is associated with higher colorectal cancer and transplant risk. Journal of Internal Medicine. https://doi.org/10.1111/joim.70026

Vancouver

Niu C, Zhang J, Bhatta P, Zhu K, Jadhav N, Okolo PI, et al. Coexisting inflammatory bowel disease in primary sclerosing cholangitis is associated with higher colorectal cancer and transplant risk. Journal of Internal Medicine. 2025. doi:10.1111/joim.70026

BibTeX
@article{Niu2025,
  author = {Niu, Chengu and Zhang, Jing and Bhatta, Prajjwol and Zhu, Kaiwen and Jadhav, Nagesh and Okolo, Patrick I and Mushtaq, Asim and Daglilar, Ebubekir},
  title = {Coexisting inflammatory bowel disease in primary sclerosing cholangitis is associated with higher colorectal cancer and transplant risk},
  journal = {Journal of Internal Medicine},
  year = {2025},
  doi = {10.1111/joim.70026}
}
Kostenlos starten →